This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruchfeld, J.
Right arrow Articles by Lindquist, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruchfeld, J.
Right arrow Articles by Lindquist, L.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2002, p. 1636-1643, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1636-1643.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Molecular Epidemiology and Drug Resistance of Mycobacterium tuberculosis Isolates from Ethiopian Pulmonary Tuberculosis Patients with and without Human Immunodeficiency Virus Infection

Judith Bruchfeld,1* Getachew Aderaye,2 Ingela Berggren Palme,1 Bjarne Bjorvatn,3 Solomon Ghebremichael,4 Sven Hoffner,4 and Lars Lindquist1

Division of Infectious Diseases, Institution of Medicine, Karolinska Institute, Huddinge University Hospital, 141 86 Stockholm,1 Department of Bacteriology, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden,4 Department of Internal Medicine, Faculty of Medicine, Black Lion University Hospital, Addis Ababa, Ethiopia,2 Department of Microbiology and Immunology, The Gade Institute, Haukeland University Hospital, 5021 Bergen, Norway3

Received 21 November 2001/ Returned for modification 14 January 2002/ Accepted 12 February 2002

We have analyzed the molecular epidemiology and drug resistance of 121 Mycobacterium tuberculosis isolates from consecutive patients with culture-positive pulmonary tuberculosis attending a university hospital outpatient department in Addis Ababa, Ethiopia. Restriction fragment length polymorphism analysis and spoligotyping were used to analyze the DNA fingerprinting patterns. Fifty-one (41.2%) of the isolates were found in 13 clusters with two or more identical DNA patterns. Two such clusters contained 49.0% of all clustered isolates. In a multivariate logistic regression model, human immunodeficiency virus (HIV)-positive serostatus was significantly associated with clustering of isolates for patients of both sexes (odds ratio [OR], 2.55; 95% confidence interval [CI], 1.17 to 5.80). There was a trend toward increased clustering of isolates from tuberculous women residing in Addis Ababa (OR, 2.10; 95% CI, 0.85 to 5.25). In total, 17 of 121 isolates (14.0%) were resistant to one or more of the antituberculosis drugs isoniazid (8.3%), streptomycin (7.4%), rifampin (2.5%), and ethambutol (1.7%). The high rate of drug-resistant isolates (29.6%) coincided with the peak prevalence of HIV infection (77.8%) in patients 35 to 44 years old. The majority (62.5%) of resistant isolates in this group were found within clusters. The simultaneous accumulation of certain bacterial clones in a patient population likely reflects recent transmission. Hence, we conclude that tuberculosis is commonly caused by recent infection with M. tuberculosis in HIV-positive Ethiopian patients. Furthermore, with the rapidly increasing prevalence of HIV infection in Ethiopia, the burden of tuberculosis, including drug-resistant tuberculosis, is likely to increase. Strengthening of classical tuberculosis control measures by promoting active case finding among HIV-positive adults with tuberculosis is warranted to reduce rates of transmission.


* Corresponding author. Mailing address: Dept. of Infectious Diseases, I 73, Huddinge University Hospital, 141 86 Huddinge, Sweden. Phone: 0046-8-58581933. Fax: 0046-8-58581916. E-mail: Judith.Bruchfeld{at}medhs.ki.se.


Journal of Clinical Microbiology, May 2002, p. 1636-1643, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1636-1643.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Diguimbaye, C., Hilty, M., Ngandolo, R., Mahamat, H. H., Pfyffer, G. E., Baggi, F., Tanner, M., Schelling, E., Zinsstag, J. (2006). Molecular Characterization and Drug Resistance Testing of Mycobacterium tuberculosis Isolates from Chad. J. Clin. Microbiol. 44: 1575-1577 [Abstract] [Full Text]